Johnson & Johnson Establishes Its First China Innovation Hub in Beijing, Unveils Localized High-End Product Lines

From "Cost Basin" to "Innovation Highland": China’s Market Role in Multinational Enterprises is Undergoing a Transformation.

01

The First in China

Johnson & Johnson China Science and Technology Innovation Center to Settle in Beijing

Today (July 14),Johnson & Johnson and Beijing Municipal Health CommissionJointly Announced the AchievementStrategic Cooperation, the two parties signed a strategic cooperation memorandum, establishing thatEstablish Johnson & Johnson China Innovation Center in Beijing(hereinafter referred to as "Innovation Center").

The Innovation Center is Johnson & Johnson Medical TechnologyThe first empowerment matrix in China that integrates "industry, academia, research, and application", the Sci-Tech Innovation Center will focus on laying outDigital Healthcare Innovation, Professional Talent IncubationAndClinical Application of ElectrophysiologyThree Major Strategic Areas: Accelerating the Integration and Resonance of Global Resources with Chinese Innovation.

“This collaboration marks another significant milestone in the upgrade of Johnson & Johnson's global innovation strategy in China, further demonstrating our long-term commitment to the healthcare事业 in China.".\" said Zhou Mintao, President of Johnson & Johnson Medical Technology China, \"Beijing boasts top clinical resources, profound scientific research capabilities, and an open policy environment, providing an ideal breeding ground for medical technology innovation. We look forward to leveraging the Johnson & Johnson Medical Technology China Science and Technology Innovation Center to connect global production and research capabilities with Chinese clinical medical expertise, empowering each other in both directions, so that the next generation of medical technology solutions can benefit more patients in China.\"

The Sci-Tech Innovation Center will fullyUpgrade Johnson & Johnson China Academic Center, simultaneouslyEstablish Johnson & Johnson China Digital Innovation Center, Global Electrophysiology Application and Training Center。

Since 2005, Johnson & Johnson has established the Johnson & Johnson China Academic Center in China. Johnson & Johnson stated,This comprehensive upgrade will focus on meeting the training programs and facilities required for future medical scenarios., New AdditionNatural Orifice Robotics Surgery, Heart Failure Management and Structural Heart InterventionsTraining base in specialized fields such as...Johnson & Johnson China Digital Innovation CenterWill focus on developing artificial intelligence, smart surgery, and digital diagnostic assistance technologies.In cutting-edge medical technology fields;Global Electrophysiology Application and Training CenterEstablished by Johnson & Johnson Medical in ChinaThe First Professional Research and Training Center Focused on Electrophysiology, the center will be based in Beijing, radiating to nearly a thousand medical institutions across China.

02

Introducing Multiple High-End Product Lines

Multinational Medical Device Companies' Localization Strategy Fully Upgraded

With the rapid development of the economy and society, China has built up a new locational advantage for multinational enterprises to develop and invest in China. China not only has a vast market but also possesses a complete industrial and supply chain system, and its modern infrastructure construction provides great convenience for foreign investment.

With the comprehensive upgrade of talent resources and the globally leading digital economy, the past model of单纯的技术输出 (pure technology export) no longer fits the development of the local market. The Chinese market is transitioning from a "cost洼地 (low-cost area)" to an "innovation高地 (high ground)."

In the medical device field, domestically-produced products have largely replaced imports in the mid-to-low-end market, and domestic companies are rapidly advancing into the high-end market.In the new competitive environment, multinational companies are gradually accelerating the growth rate of R&D and innovation investment in China.

According to the report by the "People's Forum" magazine,Since 2020, the growth rate of foreign investment in R&D has rebounded to around 10%., indicating that the trend of foreign-funded localized R&D is continuously strengthening.

Recently, Johnson & Johnson Medical Technology announced the launchSuzhou Industrial Park Surgical Factory Capacity Upgrade Project, plans to relocate the original facility located at Xingpu Road, Suzhou Industrial Park.The entire production line of surgical staplers has been relocated to the Changyang Street Johnson & Johnson Medical Technology Suzhou Industrial Park.，And upgrade to an intelligent manufacturing cluster and supply chain base。

In 2019, the Johnson & Johnson Medical Technology Surgical Factory was officially established in Suzhou. Over the past six years, the surgical factory has gradually built a production system covering multiple categories——Starting from the first stapler production line, followed by the introduction of high-end product lines such as sutures and ultrasonic scalpels, accelerating localization to quickly respond to the needs of the Chinese market.. This time, the relocation of the stapler production line to the Suzhou Industrial Park isKey Initiatives for Johnson & Johnson Medical Technology Surgical Plant Resource Integration and Capability Advancement。

Also making efforts in the high-end field of the Chinese market is GE Healthcare. Recently, located in Chengdu Tianfu International Bio City,GE HealthcareThe first phase of China's Precision Medicine Industrialization Base has successfully passed the completion and parallel acceptance, marking itsThe First High-End Equipment Industrialization Base for Precision Medicine in Western China Officially Completed and Put into Operation。

The first phase of the project focuses on key equipment in nuclear medicine —CyclotronThe localized production in China is a key step in accelerating the comprehensive localization strategy since its independent listing in 2023.

Medtronic has also established an innovation hub in Beijing.Located in Beijing Economic and Technological Development Zone, the International Medical Innovation Park (Biopark) is Medtronic's digital healthcare innovation base. It will become a super hub for Medtronic to connect its global R&D capabilities with Chinese ecosystem partners.

June,Philips(China) Investment Co., Ltd. &StrongLink Intelligence Creation, PerseTechChinese companies sign cooperation memorandums to deepen collaboration in areas such as AI-integrated treatment ecosystem platform construction.

In response to the evolving market environment in China, multinational medical device companies need to react quickly to meet Chinese demands. "Moving R&D centers to China" is becoming a unified strategy for these companies—developing locally in China, sharing globally, and shifting China’s role as a global innovation driver from manufacturing to innovation.

END

Content Communication:In ChinaJohnson（WeChat nrzx0321）